Merdury Biopharmaceutical Corporation (TPEX:6932)
6.08
+0.13 (2.18%)
Jul 9, 2026, 1:27 PM CST
-39.50% (1Y)
| Market Cap | 2.57B -46.9% |
| Revenue (ttm) | n/a |
| Net Income | -67.23M |
| EPS | -0.16 |
| Shares Out | 422.03M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 126,426 |
| Open | 5.98 |
| Previous Close | 5.95 |
| Day's Range | 5.81 - 6.09 |
| 52-Week Range | 4.95 - 12.20 |
| Beta | -1.22 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 10, 2026 |